Rheumatrex, Methotrexate Newswire

Rheumatrex, Methotrexate Newswire

Comprehensive Real-Time News Feed for Rheumatrex, Methotrexate (generic).

Results 1 - 20 of 387 in Rheumatrex, Methotrexate (generic)

  1. Newberg's miracle twins celebrate first birthdayRead the original story w/Photo

    22 hrs ago | Portland Tribune

    Newberg parents Jourdan and Matt Moore, 32 and 33, will celebrate their twins' first birthday this month, a momentous occasion for any young family. But it's a particularly special milestone in the Moores' case as the occasion is a reminder of the long road they've traveled to start their family, the obstacles that popped up at every turn and the fact that their children survived, literally, against the odds.

    Comment?

  2. Epicure: a European epidemiological study of patients with an...Read the original story w/Photo

    Thursday Sep 22 | BioMed Central

    Platinum-based systemic chemotherapy is considered the backbone for management of advanced urothelial carcinomas. However there is a lack of real world data on the use of such chemotherapy regimens, on patient profiles and on management after treatment failure.

    Comment?

  3. GSK announces US regulatory submission for sirukumab in rheumatoid arthritisRead the original story

    Friday Sep 23 | PressReleasePoint

    Sirukumab is being co-developed for RA as part of a collaboration with Janssen Biologics [Janssen], an affiliate of JBI. Paul-Peter Tak, GSK's Chief Immunology Officer & Senior Vice President R&D Pipeline, said: "We are pleased with the progress being made to seek regulatory approval of sirukumab in adult patients who, despite the use of conventional and biologic therapies, still suffer from moderately to severely active rheumatoid arthritis.

    Comment?

  4. Janssen Submits Application Seeking Approval of Sirukumab in United States for Rheumatoid ArthritisRead the original story w/Photo

    Friday Sep 23 | Freshnews

    Janssen Biotech, Inc. announced today the submission of a Biologics License Application to the United States Food and Drug Administration seeking approval of sirukumab for the treatment of adult patients with moderately to severely active rheumatoid arthritis .

    Comment?

  5. AIDS Related Primary CNS Lymphoma Market Global Industry Analysis, size, share and Forecast 2016-2026Read the original story

    Friday Sep 23 | Emailwire.com

    Future Market Insights has announced the addition of the 'AIDS Related Primary CNS Lymphoma Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering. Acquired immunodeficiency syndrome is a viral disease of immune system caused by the infection of human immunodeficiency virus .

    Comment?

  6. Hypoxia promotes chemoresistance in acute lymphoblastic leukemia cell ...Read the original story w/Photo

    Wednesday Sep 21 | BioMed Central

    Several studies show that bone marrow microenvironment and hypoxia condition can promote the survival of leukemic cells and induce resistance to anti-leukemic drugs. However, the molecular mechanism for chemoresistance by hypoxia is not fully understood.

    Comment?

  7. Shedding light on the mutational landscape of the most common pediatric cancerRead the original story w/Photo

    Thursday Sep 22 | PhysOrg Weblog

    A group of researchers from Columbia University, Rutgers University, and institutions in Europe and Japan have identified genomic alterations in pediatric relapsed acute lymphoblastic leukemia that cause both therapy resistance and improved clinical response to multi-agent chemotherapy treatment. Rutgers Cancer Institute of New Jersey researcher Hossein Khiabanian, PhD, an assistant professor of pathology, was involved in the work in the Rabadan and Ferrando laboratories at Columbia University.

    Comment?

  8. Scientists discover genomic alterations in pediatric relapsed ALLRead the original story w/Photo

    Wednesday Sep 21 | Medical News

    A group of researchers from Columbia University, Rutgers University, and institutions in Europe and Japan have identified genomic alterations in pediatric relapsed acute lymphoblastic leukemia that cause both therapy resistance and improved clinical response to multi-agent chemotherapy treatment. Rutgers Cancer Institute of New Jersey researcher Hossein Khiabanian, PhD, an assistant professor of pathology, was involved in the work in the Rabadan and Ferrando laboratories at Columbia University.

    Comment?

  9. Study compares treatments options for patients with rheumatoid...Read the original story w/Photo

    Wednesday Sep 21 | Medical News Today

    Among patients with rheumatoid arthritis previously treated with anti-tumor necrosis factor drugs but with insufficient response, a non-TNF biologic agent was more effective in achieving a good or moderate disease activity response at 24 weeks than was a second anti-TNF medication, according to a study appearing in JAMA . Tumor necrosis factor I inhibitors have improved the quality of life for patients with rheumatoid arthritis who show insufficient response to the agent methotrexate.

    Comment?

  10. Antares Pharma To Present At The Healthcare ConferenceRead the original story

    Monday Sep 19 | BioSpace

    Antares Pharma, Inc. today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Ladenburg Thalmann 2016 Healthcare Conference on Tuesday, September 27, 2016 at 2:30 p.m. Eastern Time. A live webcast of the presentation will be available via the webcast tab under the Investor Information page of the Antares website, www.antarespharma.com .

    Comment?

  11. Antares Pharma to Present at the Ladenburg Thalmann 2016 Healthcare ConferenceRead the original story

    Tuesday Sep 20 | P&T Community

    Antares Pharma, Inc. today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Ladenburg Thalmann 2016 Healthcare Conference on Tuesday, September 27, 2016 at 2:30 p.m. Eastern Time. A live webcast of the presentation will be available via the webcast tab under the Investor Information page of the Antares website, www.antarespharma.com .

    Comment?

  12. Pfizer Announces Positive Top-Line Results From REFLECTIONS B537-02...Read the original story

    Sunday Sep 18 | BioSpace

    Pfizer Inc. announced the confirmatory study evaluating the efficacy, safety, and immunogenicity of PF-06438179 compared to RemicadeA met its primary endpoint. The trial demonstrated equivalent efficacy of the proposed biosimilar PF-06438179 to the originator product as measured by the American College of Rheumatology 20 response at Week 14. PF-06438179 is being developed as a potential biosimilar to Remicade.

    Comment?

  13. Bobridge, Trott latest targets of 'Fancy Bears' WADA hackRead the original story w/Photo

    Friday Sep 16 | Cycling News

    Silver medallists Australia's Michael Hepburn, Australia's Jack Bobridge and Australia's Sam Welsford, gold medallists Britain's Owain Doull, Britain's Edward Clancy, Britain's Steven Burke and Britain's Bradley Wiggins and bronze medallists Denmark's Lasse Norman Hansen, Denmark's Niklas Larsen, Denmark's Frederik Madsen and Denmark's Casper Von Folsach pose on the podium after the men's Team Pursuit Jack Bobridge and Laura Trott became the latest targets of hackers who accessed the confidential medical records in the World Anti-Doping Agency's Anti-Doping Administration and Management System database. Hackers 'Fancy Bears' accessed data on the 2016 Olympians via a phishing attack on the International Olympic Committee.

    Comment?

  14. Pfizer Announces Positive Top-Line Results from REFLECTIONS B537-02...Read the original story w/Photo

    Friday Sep 16 | Freshnews

    Pfizer Inc. announced the confirmatory study evaluating the efficacy, safety, and immunogenicity of PF-06438179 compared to RemicadeA met its primary endpoint. The trial demonstrated equivalent efficacy of the proposed biosimilar PF-06438179 to the originator product as measured by the American College of Rheumatology 20 response at Week 14. PF-06438179 is being developed as a potential biosimilar to Remicade.

    Comment?

  15. Expert tells inquiry consultant wrong to make ectopic pregnancy diagnosisRead the original story w/Photo

    Thursday Sep 15 | Independent.ie

    A gynaecologist has said a doctor at the centre of a medical inquiry was "not entitled" to recommend medication that would end a mother's early pregnancy. A gynaecologist has said a doctor at the centre of a medical inquiry was "not entitled" to recommend medication that would end a mother's early pregnancy.

    Comment?

  16. Inquiry hears evidence over ultrasoundsRead the original story w/Photo

    Thursday Sep 15 | RTE.ie

    A Medical Council inquiry into allegations that a doctor wrongly diagnosed a pregnancy as ectopic has heard evidence that a scan at another hospital did not detect a foetal heartbeat. It is claimed that a doctor at South Tipperary General Hospital 'Dr A' - wrongly diagnosed an ectopic pregnancy in a patient in January 2013, when the pregnancy was actually in the womb.

    Comment?

  17. Scan showed up 'possible' pregnancy, inquiry toldRead the original story w/Photo

    Wednesday Sep 14 | Independent.ie

    A Medical Council inquiry into a claim that a woman received a wrong diagnosis of an ectopic pregnancy heard that a scan later revealed a "possible" pregnancy in the womb. A Medical Council inquiry into a claim that a woman received a wrong diagnosis of an ectopic pregnancy heard that a scan later revealed a "possible" pregnancy in the womb.

    Comment?

  18. Fetal scan found 'possible pregnancy' - inquiryRead the original story w/Photo

    Wednesday Sep 14 | RTE.ie

    A Medical Council inquiry resumed into allegations that a consultant obstetrician at South Tipperary General Hospital wrongly diagnosed a pregnancy as ectopic, when it may have been a viable pregnancy in the womb. Day three of the inquiry heard a written statement from Dr Siobhan Corcoran, who was a specialist registrar at Cork University Hospital, on 26 January 2013.

    Comment?

  19. Scan revealed 'possible' pregnancy in womb after earlier 'ectopic diagnosis' - inquiry hearsRead the original story w/Photo

    Wednesday Sep 14 | Independent.ie

    A Medical Council inquiry into a claim that a woman received a wrong diagnosis of an ectopic pregnancy was informed today that a scan later revealed a "possible" pregnancy in the womb. A Medical Council inquiry into a claim that a woman received a wrong diagnosis of an ectopic pregnancy was informed today that a scan later revealed a "possible" pregnancy in the womb.

    Comment?

  20. Doctor saw signs of early pregnancy after 'ectopic diagnosis'Read the original story w/Photo

    Tuesday Sep 13 | Independent.ie

    A top obstetric expert said she saw signs of early pregnancy in a woman who was told she had suffered an ectopic pregnancy. A top obstetric expert said she saw signs of early pregnancy in a woman who was told she had suffered an ectopic pregnancy.

    Comment?